ALICIA RENNA: Open Payments
NPI 1487913828 · COATESVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,818 in 143 payments from 17 companies in 2025. Trend: 2023 $1,407 · 2024 $2,782 · 2025 $2,818
Food & beverage: $2,733Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $620 |
| Janssen Biotech, Inc. | 29 | $573 |
| Phathom Pharmaceuticals, Inc. | 9 | $241 |
| Madrigal Pharmaceuticals | 10 | $241 |
| Ardelyx, Inc. | 15 | $225 |
| PFIZER INC. | 14 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $188 |
| GENZYME CORPORATION | 7 | $165 |
| Lilly USA, LLC | 3 | $80 |
| Gilead Sciences, Inc. | 4 | $73 |
Products named: TREMFYA, VOQUEZNA, REZDIFFRA, IBSRELA, MAVYRET, DUPIXENT, XELJANZ, RINVOQ.
Industry payments across PA — which companies pay providers there.
